Education
About Us
Working with TipRanks
Follow Us
Masimo Corp. (MASI)
:MASI
MASI Stock Chart & Stats
$142.14
$0.33(0.20%)
At close: 4:00 PM EST
$142.14
$0.33(0.20%)
Day’s Range― - ―
52-Week Range$133.70 - $194.88
Previous CloseN/A
Volume102.94K
Average Volume (3M)740.69K
Market Cap
$8.12B
Enterprise Value$7.96B
Total Cash (Recent Filing)$314.70M
Total Debt (Recent Filing)$586.20M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Mar 03, 2026EPS Estimate
1.46Last Dividend Ex-Date
Nov 23, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)1.32
Shares Outstanding53,713,947
10 Day Avg. Volume1,030,492
30 Day Avg. Volume740,686
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)8.66
Price to Sales (P/S)4.35
P/FCF Ratio51.66
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue4.64
Enterprise Value/Gross Profit8.45
Enterprise Value/Ebitda-111.85
Forecast
1Y Price Target
$161.00Price Target Upside13.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMASI's 3Q25 revenue and EPS beat consensus.
Legal VictoryMASI announced a favorable jury verdict in its patent litigation against Apple, resulting in an award of $634M in damages.
Strategic PartnershipsMasimo renewed and expanded its partnership with Philips, highlighting ongoing strategic collaborations.
Bears Say
Legal ChallengesApple is expected to file an appeal in the patent litigation case, potentially delaying MASI's collection of the $634M of damages by 1.5 to 2 years.
Operational RisksRisks include lower utilization with Medicaid/ACA cuts, increased competitive pressures, tariffs, cost inflation, and commercial disruption from territory/leadership changes.
Valuation ConcernsCurrent valuation already reflects much of the margin upside, and revenue growth is not expected to materially accelerate higher soon.
Masimo News
MASI FAQ
What was Masimo Corp.’s price range in the past 12 months?
Masimo Corp. lowest stock price was $133.70 and its highest was $194.88 in the past 12 months.
What is Masimo Corp.’s market cap?
Masimo Corp.’s market cap is $8.12B.
When is Masimo Corp.’s upcoming earnings report date?
Masimo Corp.’s upcoming earnings report date is Mar 03, 2026 which is in 99 days.
How were Masimo Corp.’s earnings last quarter?
Masimo Corp. released its earnings results on Nov 04, 2025. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.214 by $0.106.
Is Masimo Corp. overvalued?
According to Wall Street analysts Masimo Corp.’s price is currently Undervalued.
Does Masimo Corp. pay dividends?
Masimo Corp. pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp. dividends here
What is Masimo Corp.’s EPS estimate?
Masimo Corp.’s EPS estimate is 1.46.
How many shares outstanding does Masimo Corp. have?
Masimo Corp. has 53,713,947 shares outstanding.
What happened to Masimo Corp.’s price movement after its last earnings report?
Masimo Corp. reported an EPS of $1.32 in its last earnings report, beating expectations of $1.214. Following the earnings report the stock price went down -4.61%.
Which hedge fund is a major shareholder of Masimo Corp.?
Currently, no hedge funds are holding shares in MASI
Masimo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$161.00 (13.27% Upside)
$161.00 (13.27% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 921.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $468.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.63%
12-Months-Change
Fundamentals
Return on Equity
-17.93%
Trailing 12-Months
Asset Growth
-41.14%
Trailing 12-Months
Company Description
Masimo Corp.
Masimo Corporation (NASDAQ: MASI) is a global medical technology company that specializes in noninvasive monitoring technologies, primarily focusing on the measurement of blood oxygen levels and other vital signs. Founded in 1989, Masimo is known for its innovative products that enhance patient care and improve clinical outcomes across various healthcare settings, including hospitals and home care. The company's core products include its pulse oximetry devices, brain function monitoring systems, and noninvasive hemoglobin measurement technologies, which are widely used in anesthesia, critical care, and emergency medicine.
MASI Company Deck
MASI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Masimo delivered strong financial performance with significant revenue growth, operating margin expansion, and increased EPS. Strategic partnerships and shareholder returns were also notable achievements. However, challenges such as a decline in gross margin due to tariffs, and lower-than-expected consumables growth, along with tightened revenue guidance, presented some concerns.View all MASI earnings summariesMASI Stock 12 Month Forecast
Average Price Target
$161.00
▲(13.27% Upside)
Technical Analysis
Ownership Overview
8.76% Insiders
37.72% Mutual Funds
10.02% Other Institutional Investors
22.56% Public Companies and
Individual Investors